Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
| ▸ | ALPL | P05186 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6981678 | 0.92 | GABRA1 (0.46) | GABRA1GABRA5CNR1CNR2CYP11B1 | |
| SCHEMBL6977175 | 0.89 | GABRA1 (0.39) | GABRA1GABRA5CNR1CNR2CYP11B1 | |
| SCHEMBL6982921 | 0.89 | PTGDR2 (0.43) | GABRA1GABRA5CNR1CNR2CYP11B1 | |
| SCHEMBL6981471 | 0.89 | GABRA5 (0.43) | GABRA1GABRA5CNR1CNR2CYP11B1 | |
| SCHEMBL6979014 | 0.88 | GABRA1 (0.41) | GABRA1GABRA5CNR1CNR2CYP11B1 | |
| SCHEMBL6975201 | 0.87 | GABRA1 (0.43) | GABRA1GABRA5CYP11B1CYP11B2ALDH1A1 | |
| SCHEMBL6973875 | 0.84 | GABRA1 (0.42) | GABRA1GABRA5CYP11B1CYP11B2ALDH1A1 | |
| SCHEMBL6980050 | 0.83 | GABRA1 (0.39) | GABRA1GABRA5CNR1CNR2CYP11B1 | |
| SCHEMBL6983481 | 0.81 | GABRA1 (0.38) | GABRA1GABRA5CNR1CNR2TP53 | |
| SCHEMBL7674354 | 0.81 | GABRA1 (0.39) | GABRA1GABRA5CNR1CNR2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0985671-B1 | PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT | MOCHIDA PHARM CO LTD (JP) | 2003-04-02 | — | — | EP | disclosed |
| US-6197768-B1 | THERAPY, PREVENTION ISCHEMIC HEART DISEASE | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2001-03-06 | — | — | US | disclosed |
| EP-0985671-A1 | PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2000-03-15 | — | — | EP | disclosed |
| US-6018046-A | SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2000-01-25 | — | — | US | disclosed |